VP-16, Ifosfamide, Dexamethasone, L-asparaginase Chemotherapy in Patients With Extranodal Natural Killer T Cell Lymphoma (VIDL+ASCT)
Clinical trial NCT02544425 · UNKNOWN
Trial details
- NCT number
- NCT02544425
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-21
- Primary completion
- 2021-08-31
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.